Search results
Sanofi (SNY) Dupixent Esophagitis Kids Study Meets Goal
Zacks via Yahoo Finance· 2 years agoSanofi's (SNY) Dupixent shows the potential to improve signs of eosinophilic esophagitis in a phase...
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
Zacks via Yahoo Finance· 5 months agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced positive study data on the...
Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years
Benzinga via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) Phase 3 trial of Dupixent...
Regeneron (REGN), Sanofi's Dupixent Gets Label Update in US
Zacks via Yahoo Finance· 3 months agoThe FDA updates Regeneron (REGN) and Sanofi's Dupixent label in the United States to include...
Pharma Stock Roundup: MRK Buys Cancer Drug Rights, SNY Dupixent Kids Study Succeeds
Zacks via Yahoo Finance· 2 years agoThis week, Merck MRK in-licensed co-development rights to Orion Corporation’s prostate cancer...
Regeneron (REGN) Q3 Earnings & Sales Beat on Eylea, Dupixent
Zacks via Yahoo Finance· 1 year agoRegeneron (REGN) tops earnings and sales estimates for the third quarter, driven by its lead drug...
US FDA approves Dupixent to treat younger kids with esophageal condition
Reuters via Yahoo News· 3 months ago(Reuters) -The U.S. health regulator has approved the use of Regeneron and Sanofi's Dupixent to...
Regeneron Jumps On Third-Quarter Beat As High-Dose Eylea Delivers
Investor's Business Daily· 6 months agoRegeneron Pharmaceuticals' high-dose Eylea is off to a strong start in the U.S., the company said...
Sanofi - Regeneron Tout Additional Positive Data From Flagship Dupixent Product
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) presented more positive...
Will Eylea, Dupixent Buoy Regeneron's (REGN) Q1 Earnings?
Zacks via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals, Inc. REGN is scheduled to release first-quarter 2022 results on May 4,...